The Non-Alcoholic Fatty Liver Disease (NAFLD) Drugs Market size is expected to grow at an annual average of 57% during 2021-2027. Nonalcoholic steatohepatitis is a form of liver disease that occurs in people who consume little or no alcohol. Nonalcoholic steatohepatitis (NASH) is one of the most common liver diseases, often called silent liver disease. […]
